COURTNEY HENDRICK: Open Payments
NPI 1366817686 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$775 in 41 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $26 · 2025 $775
Food & beverage: $775
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $194 |
| Amgen Inc. | 6 | $110 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $95 |
| AstraZeneca Pharmaceuticals LP | 5 | $80 |
| PFIZER INC. | 3 | $67 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| Lilly USA, LLC | 2 | $52 |
| ALK-Abello, Inc | 1 | $31 |
| Medtronic, Inc. | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $17 |
Products named: Rybelsus, Kerendia, OTEZLA, ELIQUIS, Ozempic, TRELEGY ELLIPTA, JARDIANCE, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
